Cargando…
Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972–1980
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439418/ https://www.ncbi.nlm.nih.gov/pubmed/28428368 http://dx.doi.org/10.2337/dc17-er06d |
| _version_ | 1783237946802962432 |
|---|---|
| author | Aroda, Vanita R. Rosenstock, Julio Wysham, Carol Unger, Jeffrey Bellido, Diego González-Gálvez, Guillermo Takami, Akane Guo, Hailing Niemoeller, Elisabeth Souhami, Elisabeth Bergenstal, Richard M. |
| author_facet | Aroda, Vanita R. Rosenstock, Julio Wysham, Carol Unger, Jeffrey Bellido, Diego González-Gálvez, Guillermo Takami, Akane Guo, Hailing Niemoeller, Elisabeth Souhami, Elisabeth Bergenstal, Richard M. |
| author_sort | Aroda, Vanita R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5439418 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-54394182018-06-01 Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972–1980 Aroda, Vanita R. Rosenstock, Julio Wysham, Carol Unger, Jeffrey Bellido, Diego González-Gálvez, Guillermo Takami, Akane Guo, Hailing Niemoeller, Elisabeth Souhami, Elisabeth Bergenstal, Richard M. Diabetes Care Errata American Diabetes Association 2017-06 2017-04-20 /pmc/articles/PMC5439418/ /pubmed/28428368 http://dx.doi.org/10.2337/dc17-er06d Text en © 2017 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license. |
| spellingShingle | Errata Aroda, Vanita R. Rosenstock, Julio Wysham, Carol Unger, Jeffrey Bellido, Diego González-Gálvez, Guillermo Takami, Akane Guo, Hailing Niemoeller, Elisabeth Souhami, Elisabeth Bergenstal, Richard M. Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972–1980 |
| title | Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972–1980 |
| title_full | Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972–1980 |
| title_fullStr | Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972–1980 |
| title_full_unstemmed | Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972–1980 |
| title_short | Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972–1980 |
| title_sort | erratum. efficacy and safety of lixilan, a titratable fixed-ratio combination of insulin glargine plus lixisenatide in type 2 diabetes inadequately controlled on basal insulin and metformin: the lixilan-l randomized trial. diabetes care 2016;39:1972–1980 |
| topic | Errata |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439418/ https://www.ncbi.nlm.nih.gov/pubmed/28428368 http://dx.doi.org/10.2337/dc17-er06d |
| work_keys_str_mv | AT arodavanitar erratumefficacyandsafetyoflixilanatitratablefixedratiocombinationofinsulinglarginepluslixisenatideintype2diabetesinadequatelycontrolledonbasalinsulinandmetforminthelixilanlrandomizedtrialdiabetescare20163919721980 AT rosenstockjulio erratumefficacyandsafetyoflixilanatitratablefixedratiocombinationofinsulinglarginepluslixisenatideintype2diabetesinadequatelycontrolledonbasalinsulinandmetforminthelixilanlrandomizedtrialdiabetescare20163919721980 AT wyshamcarol erratumefficacyandsafetyoflixilanatitratablefixedratiocombinationofinsulinglarginepluslixisenatideintype2diabetesinadequatelycontrolledonbasalinsulinandmetforminthelixilanlrandomizedtrialdiabetescare20163919721980 AT ungerjeffrey erratumefficacyandsafetyoflixilanatitratablefixedratiocombinationofinsulinglarginepluslixisenatideintype2diabetesinadequatelycontrolledonbasalinsulinandmetforminthelixilanlrandomizedtrialdiabetescare20163919721980 AT bellidodiego erratumefficacyandsafetyoflixilanatitratablefixedratiocombinationofinsulinglarginepluslixisenatideintype2diabetesinadequatelycontrolledonbasalinsulinandmetforminthelixilanlrandomizedtrialdiabetescare20163919721980 AT gonzalezgalvezguillermo erratumefficacyandsafetyoflixilanatitratablefixedratiocombinationofinsulinglarginepluslixisenatideintype2diabetesinadequatelycontrolledonbasalinsulinandmetforminthelixilanlrandomizedtrialdiabetescare20163919721980 AT takamiakane erratumefficacyandsafetyoflixilanatitratablefixedratiocombinationofinsulinglarginepluslixisenatideintype2diabetesinadequatelycontrolledonbasalinsulinandmetforminthelixilanlrandomizedtrialdiabetescare20163919721980 AT guohailing erratumefficacyandsafetyoflixilanatitratablefixedratiocombinationofinsulinglarginepluslixisenatideintype2diabetesinadequatelycontrolledonbasalinsulinandmetforminthelixilanlrandomizedtrialdiabetescare20163919721980 AT niemoellerelisabeth erratumefficacyandsafetyoflixilanatitratablefixedratiocombinationofinsulinglarginepluslixisenatideintype2diabetesinadequatelycontrolledonbasalinsulinandmetforminthelixilanlrandomizedtrialdiabetescare20163919721980 AT souhamielisabeth erratumefficacyandsafetyoflixilanatitratablefixedratiocombinationofinsulinglarginepluslixisenatideintype2diabetesinadequatelycontrolledonbasalinsulinandmetforminthelixilanlrandomizedtrialdiabetescare20163919721980 AT bergenstalrichardm erratumefficacyandsafetyoflixilanatitratablefixedratiocombinationofinsulinglarginepluslixisenatideintype2diabetesinadequatelycontrolledonbasalinsulinandmetforminthelixilanlrandomizedtrialdiabetescare20163919721980 |